Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L STEIN

Showing results (61-70 of 1,757) with videos related to

Pageof 176
Sort By:
Drug Discovery Today|March 8, 2003
A new model for drug discovery--meeting our societal obligationRoss L Stein
Current Biology : CB|August 1, 1991
Exploring the catalytic activity of immunophilinsR L Stein
Leukemia & Lymphoma|October 27, 2022
JAK inhibition in myelofibrosis: how to sequence treatment in this new era of multiple optionsBrady L Stein
Current Alzheimer Research|January 29, 2008
A new model for academics based drug discoveryRoss L Stein
Archives of Biochemistry and Biophysics|February 1, 1985
Catalysis by human leukocyte elastase: III. Steady-state kinetics for the hydrolysis of p-nitrophenyl estersR L Stein
Current Hematologic Malignancy Reports|September 9, 2021
Management of Myelofibrosis-Associated Anemia: Focus on Standard Agents and Novel Therapeutics in Phase 3 Clinical TrialsBrady L Stein
Specifying Engineer|January 10, 1985
Understanding hospital communications systemsH L Stein
Biochemistry|January 16, 2002
Enzymatic hydrolysis of p-nitroacetanilide: mechanistic studies of the aryl acylamidase from Pseudomonas fluorescensRoss L Stein
American Journal of Hospital Pharmacy|December 1, 1980
Use of inline filters and infusion pumps with TPN solutionsR L Stein
Diseases of the Colon and Rectum|August 10, 2019
Expert Commentary on Malignant Bowel ObstructionSharon L Stein
Pageof 176

Showing results (61-70 of 1,757) with videos related to

Sort By:
Pageof 176
Drug Discovery Today|March 8, 2003
A new model for drug discovery--meeting our societal obligationRoss L Stein
Current Biology : CB|August 1, 1991
Exploring the catalytic activity of immunophilinsR L Stein
Leukemia & Lymphoma|October 27, 2022
JAK inhibition in myelofibrosis: how to sequence treatment in this new era of multiple optionsBrady L Stein
Current Alzheimer Research|January 29, 2008
A new model for academics based drug discoveryRoss L Stein
Archives of Biochemistry and Biophysics|February 1, 1985
Catalysis by human leukocyte elastase: III. Steady-state kinetics for the hydrolysis of p-nitrophenyl estersR L Stein
Current Hematologic Malignancy Reports|September 9, 2021
Management of Myelofibrosis-Associated Anemia: Focus on Standard Agents and Novel Therapeutics in Phase 3 Clinical TrialsBrady L Stein
Specifying Engineer|January 10, 1985
Understanding hospital communications systemsH L Stein
Biochemistry|January 16, 2002
Enzymatic hydrolysis of p-nitroacetanilide: mechanistic studies of the aryl acylamidase from Pseudomonas fluorescensRoss L Stein
American Journal of Hospital Pharmacy|December 1, 1980
Use of inline filters and infusion pumps with TPN solutionsR L Stein
Diseases of the Colon and Rectum|August 10, 2019
Expert Commentary on Malignant Bowel ObstructionSharon L Stein
Pageof 176